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Mitochondria have a central role in cellular metabolism; they are responsible for the biosynthesis of amino
acids, lipids, iron–sulphur clusters and regulate apoptosis. About 99% of mitochondrial proteins are
encoded by nuclear genes, so the biogenesis of mitochondria heavily depends on protein import
pathways into the organelle. An intricate system of well-studied import machinery facilitates the import
of mitochondrial proteins. In addition, folding of the newly synthesized proteins takes place in a busy
environment. A system of folding helper proteins, molecular chaperones and co-chaperones, are present
to maintain proper conformation and thus avoid protein aggregation and premature damage. The
components of the import machinery are well characterised, but the targeting signals and how they are
recognised and decoded remains in some cases unclear. Here we provide some detail on the types of
targeting signals involved in the protein import process. Furthermore, we discuss the very elaborate
chaperone systems of the intermembrane space that are needed to overcome the particular challenges
for the folding process in this compartment. The mechanisms that sustain productive folding in the face
of aggregation and damage in mitochondria are critical components of the stress response and play an
important role in cell homeostasis.nna-Roza Dimogkioka got her
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24931. Introduction
Mitochondria are subcellular organelles that are critically
important for cell physiology and development. Mitochondria
have a central role in cellular metabolism; they are responsible
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View Article Onlineclusters, haem, and lipids. In addition, they are crucial in
cellular signalling pathways and apoptosis.1,2 Moreover, mito-
chondria participate in a range of innate immunity pathways.3
Mitochondrial biogenesis requires the integration of two
genomes, the nuclear and the mtDNA genome. Despite the
plethora of mitochondrial functions, the mitochondrial
genome only codes for a small set of proteins, namely 8 proteins
in the yeast S. cerevisiae and 13 proteins in humans.4 These
proteins are all core subunits of the electron transfer complexes
located at the inner mitochondrial membrane. Approximately
99% of mitochondrial proteins are encoded by nuclear genes
and are synthesized as protein precursors in the cytosol.
Subsequently they are targeted to the surface of mitochondria
and then sorted within their specic sub-mitochondrial
compartment.5 The mitochondrial proteome contains about
1000 proteins in yeast and 1500 proteins in humans, fullling
the mitochondrion's multiple functions.1,2 Proteomic studies
have led to the functional classication of these proteins in
yeast and more recently in human mitochondria. An inventory
of a little over 1000 genes encoding the mammalian mito-
chondrial proteome, known as MitoCarta, was created in 2008.4
This was updated in 2015 to include a total of 1158 human or
mouse genes leading to MitoCarta2.0.6 The latest MitoCarta
release in 2020 includes 1136 genes with information on the
submitochondrial localisation and the mitochondrial func-
tional pathways they belong to.7
According to the inventory, the majority of the proteins are
assigned to the matrix (46%) and the inner membrane (32%).
10% are annotated as outer membrane proteins whilst only 5%
are designated as intermembrane space (IMS) proteins.7
Despite making up a small proportion of the mitochondrialErik Lacko did his early
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Edinburgh Napier University.
Following a one-year placement
at the European Molecular
Biology Laboratory (EMBL), he
is developing his scientic career
and laboratory techniques in
protein science and mitochon-
dria biology working as a research technician in the group of Prof
Kostas Tokatlidis at the University of Glasgow.
© 2021 The Author(s). Published by the Royal Society of Chemistryproteome, proteins of the outer membrane and the IMS play
a crucial role in the numerous functions of the mitochondrion.
These include, apoptosis, phospholipid biosynthesis, haem
biosynthesis and critical communications with the cytosol and
other organelles. In addition, although the IMS is the smallest
mitochondrial subcompartment, it encompasses a very wide
range of protein import mechanisms. Protein import is pivotal
for the mitochondrial intermembrane space (IMS) since all IMS
proteins are encoded by nuclear genes.2,8
In this review we discuss the import pathways required to
accommodate for the different types of proteins that are
imported into mitochondria. Furthermore, we highlight the
types and structural features of mitochondrial protein targeting
signals that underpin the different import pathways. We then
focus on the IMS, which is the only mitochondrial compartment
housing a redox modication machinery integral to the import
process. We discuss how this machinery works and how it
facilitates a chaperone-assisted folding process in this
compartment. Finally, we discuss the various chaperone
systems in the IMS which are critical for sustaining an efficient
folding environment in this compartment.2. General protein import pathways
into mitochondria
Several import pathways are needed to accommodate the
different types of proteins that are imported into mitochondria
(Fig. 1). Each of the import pathways has specialised protein
import components, many of which are encoded by genes that
are essential for cell viability.9 The precursors undertaking
a specic import pathway are guided by peptide targetingProfessor Kostas Tokatlidis is
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Fig. 1 The various import pathways of preproteins into mitochondria. Proteins targeted to the mitochondrial matrix typically follow the pre-
sequence pathway (shown in red), where they are finally modified in the matrix by matrix processing proteins (MPP, ICP or Oct). Preproteins
destined for the mitochondrial outer membrane are either integrated via the MIMmachinery or by the SAM complex (depending on whether the
protein is an a-helical protein or a b-barrel protein respectively, shown in light blue). Hydrophobic proteins destined for the inner membrane, are
targeted and carried across the IMS by the Tim9/10 complex, and inserted by the Tim22 complex (shown in green). Proteins destined for the IMS



























































































View Article Onlinesignals that are variable in length and their chemical properties
and, in some cases, not very well understood. In the next
paragraphs, we will summarise the main protein import path-
ways in terms of the components involved; the energetic
requirements and the mechanism of interactions that ensure
the efficiency of the protein import process which is key to
mitochondria biogenesis.2.1 The presequence pathway for import into the matrix
Cytosolically made proteins encoded by nuclear genes but tar-
geted to mitochondria for their function usually require
a system of mitochondrial-linked chaperones and a targeting
sequences that determine the protein's endpoint within the32478 | RSC Adv., 2021, 11, 32476–32493mitochondria. Proteins destined for mitochondria typically are
translocated as preproteins; preproteins typically contain an N-
terminal amino acid presequence that usually forms an a-helix
with positively charged residues on one side.10 This sequence is
commonly referred to as the matrix-targeting signal (MTS), and
will ultimately lead to the translocation of the protein into the
mitochondrial matrix.11
The preprotein is carried within the cytosol in an unfolded
state maintained by the cytosolic chaperones Hsp70 and
Hsp90.12 Upon close proximity with the outer membrane of the
mitochondria, the preprotein is typically recognised by the
membrane-bound receptors Tom20 and Tom22, both of which
form part of the main translocase of the outer membrane (TOM)



























































































View Article Onlineof the TOM complex.2 In addition to Tom20, Tom70 is one of
the rst identied import receptors of the mitochondrial OM.13
Both Tom20 and Tom70 have their own specic preference for
substrate, alongside the fact they are non-essential but have the
ability to rescue each other's function.14 Tom40 acts as the main
protein import channel and is encoded by an essential gene.15
Tom40 is endowed with the capacity to allow passage of almost
all proteins that are translocated to mitochondria, and it
contains a specic region for the binding of different types of
preproteins. Also included within the TOM complex are the
subunits Tom5, Tom6 and Tom7, all of which are encoded by
non-essential genes (in contrast to Tom40 which is encoded by
an essential gene) for the optimisation of the function of the
complex.16–18 The matrix targeting signal binds to a groove of
Tom20 that recognises its hydrophobic residues;19 recognition
by Tom20 leads to the binding and translocation through the
outer membrane via Tom40;20 the preprotein then interacts
with the presequence translocase of the inner membrane
known as TIM23. This interaction between the preprotein and
TIM23 drives preprotein translocation across the inner
membrane, in partnership with membrane potential (Dj).21
Coupled to the TIM23 complex is the presequence translocase-
associated motor (PAM), containing the mitochondrial version
of heat shock protein 70 (mtHsp70). This motor promotes the
unidirectional movement of preproteins into the mitochondrial
matrix in an ATP-dependent manner.22 Following successful
import, the positively charged presequence is cleaved by the
mitochondrial-processing peptidase (MPP).23,24 Additional pro-
cessing enzymes are then available to stabilize and fold the
protein into its active form. Examples include: the removal of
destabilizing amino acids by 55 kDa intermediate cleaving and
octapeptidyl peptidases (Icp55 and Oct1 respectively);25 and
correct folding via the Hsp60–Hsp10 chaperonin complex.262.2 Insertion into the inner membrane
If a protein is destined for a location other than the matrix, it
will usually include either additional targeting information on
top of the matrix targeting signal or an entirely different tar-
geting signal. Some proteins that are destined for the IMS
interact rst with the inner membrane and are then released
into the IMS. In this case, they contain a bipartite targeting
signal made of a matrix-targeting sequence followed by
a specic hydrophobic sorting signal. These proteins are
initially targeted to the TIM23 complex following the matrix-
targeting route. However, when in the TIM23 complex they get
arrested by the small hydrophobic segment which functions as
a stop-transfer signal (stop transfer pathway).27 Once stalled
within the TIM23 complex, they are then released laterally into
the inner membrane with the help of a small hydrophobic
protein known as Mgr2.28
A separate route for insertion of inner membrane proteins
exists for very hydrophobic proteins that are subunits of the
electron transport complex of the inner membrane and are
encoded by the mitochondrial DNA. These proteins are syn-
thesised in the matrix and inserted into the inner membrane
form the matrix side by the OXA insertase.29–31© 2021 The Author(s). Published by the Royal Society of ChemistryA major part of inner membrane proteins are helical multi-
spanning proteins that belong to the family of solute trans-
porters of the inner membrane. These have typically six
membrane spanning segments and are responsible for the
transport of small metabolites across the inner mitochondrial
membrane.32 The insertion of these proteins in the inner
membrane is governed by the carrier pathway.33 In this case, the
imported proteins do not contain a presequence, but instead
internal peptide sequences found within the more hydrophobic
areas of the transmembrane segments of the protein play the
role of targeting signals. Proteins with internal signals are
carried by Hsp70 and Hsp90 to the outer membrane where they
are recognised by the receptor Tom70.12 Following their release
from the cytosolic chaperones, proteins travel into the inter-
membrane space via the Tom40 channel, presumably in a loo-
ped formation.34 Small intermembrane space chaperones
known as small TIM chaperones (Tim9 and Tim10 or Tim8 and
Tim13) then bind – in a heterohexameric complex – to the
protein to prevent any aggregation occurring.34–37 Here, the
proteins are then guided by the chaperones to the translocase of
the inner membrane TIM22 complex. The TIM22 complex then
inserts the proteins in a process that depends on Dj, thus
producing a multi-spanning protein within the inner
membrane.38 The insertion of Tim23 is like the carrier pathway
as it also uses small TIM chaperones to allow transport across
the intermembrane space, albeit with the non-essential chap-
erones Tim8 and Tim13.39–41 An example of a preprotein lacking
an N-terminal presequence is the ADP/ATP carrier (AAC), as
targeting information to the inner membrane is instead found
within its three modules.422.3 Insertion into the outer membrane
The insertion of outer membrane proteins also involves the
TOM complex, amongst other complexes found within the outer
membrane. One such complex is known as the sorting and
assembly machinery (SAM) complex and is used for the inser-
tion of outer membrane b-barrel proteins.43 b-Barrel proteins
are characteristic prokaryotic proteins. Interestingly, these
proteins are also found within eukaryotic mitochondria and
chloroplasts, making their lineage unique to the rest of the
cell.14 There are three main subunits found within the SAM
machinery: Sam50 (the main component), Sam35 and Sam37.
Mitochondrial preproteins access this machinery by interaction
and translocation into the intermembrane space via the TOM
complex's Tom70 receptor and Tom40 channel. Here, the
proteins interact with the small TIM chaperones, allowing for
the integration of the precursor proteins into the SAM complex,
where they are subsequently inserted into the outer
membrane.44
Although b-barrel proteins are exclusively localised in the
outer and not the inner mitochondrial membrane, the outer
membrane also houses a-helical membrane proteins. These are
integrated in the OM by a dedicated machinery, the mito-
chondrial import complex (MIM complex).45 Single-spanning
proteins with an N-terminal anchor and multi-spanning



























































































View Article Onlineand be imported into the outer membrane directly via the MIM
complex, usually in partnership with the Tom70 receptor.46
Proteins Mim1 and Mim2 are crucial for the normal function of
the complex; complete absence of Mim2 has been shown to lead
to the impairment of mitochondrial protein import, defects in
mitochondrial morphology and problems in the assembly of the
TOM complex.472.4 Import into the intermembrane space: chemical
modication during import via an oxidation-coupled
mechanism
All proteins destined for the intermembrane space are encoded
by nuclear genes, and thus are synthesised and translocated
from the cytosol. For these proteins to reach the intermembrane
space, they can include one of two unique properties: (1) they
can contain a bipartite sequence as previously discussed, or (2)Fig. 2 The role and recycling of the Mia40 oxidoreductase within the
mature disulphide bond formation within the protein. Mia40 is subseque
re-oxidised by a number of proteins further down the chain. In aerobic co
conditions, Erv1 instead interacts with a fumarate reductase known as O
then free to re-interact with Mia40 to complete the cycle and free up M
32480 | RSC Adv., 2021, 11, 32476–32493they can be retained in the IMS by an interaction with the
mitochondrial intermembrane space import and assembly
protein 40 (Mia40).48 Bipartite sequences are targeting signals –
much like matrix targeting signals – albeit with an added
transmembrane-domain-like hydrophobic region following the
MTS as discussed in the previous section. These preproteins
following the stop transfer pathway are subject to a double
cleavage (i) by the mitochondrial processing peptidase (MPP) to
remove the MTS and (ii) by the specic intermembrane space
protease (IMP) that removes the stop transfer hydrophobic
domain –to discharge the mature protein into the intermem-
brane space. This pathway is fuelled solely by mitochondrial
membrane potential, and does not require ATP-hydrolysis in
contrast to the matrix targeting pathway where ATP hydrolysis
in the matrix is needed.11,49–51mitochondrial IMS. Proteins are actively oxidised by Mia40 leading to
ntly reduced, and then re-oxidised by the FAD-bound Erv1. Erv1 is then
nditions, Erv1 is recycled by O2 or cytochrome C (Cyt. C). In anaerobic
SM1 which in turn transports electrons to fumarate.69 Oxidised Erv1 is
ia40 to further interact with imported precursors.



























































































View Article OnlineA very substantial part of the intermembrane space proteins
contain cysteine motifs – either CX3C or CX9C – which later
become oxidised, forming strong disulphide bonds necessary
for intermembrane space protein maturation. This discovery
was based upon the presence of internal disulphides found
within the TIM intermembrane space chaperones.36,52 This
specic pathway is known as the MIA (mitochondrial protein
import and assembly) pathway (Fig. 2), as preproteins involved
in this pathway primarily interact with the oxidoreductase
protein Mia40.48 In this interaction, Mia40 is bound to the inner
membrane, leaving its C-terminus accessible to the intermem-
brane space; it is at this C-terminus where substrates interact
with the oxidoreductase protein.10 Mia40 acts by ‘donating’
disulphides to premature intermembrane space proteins, thus
leading to correct mature folding and entrapping within the
intermembrane space. Previously stated CX3C/CX9C cysteine
motifs interact with the specic substrate-binding cle within
the structure of Mia40. Here, the substrates then bind to what is
known as a CPC motif, producing a disulphide intermediate
between the substrate and Mia40.53 The specic substrate is
then subsequently oxidised with correct disulphide formation
leading to protein maturation and thus IMS protein activity.
There are many examples of substrates of Mia40 that are vital to
the normal function of mitochondria, such as the small TIM
chaperones – Tim8, Tim9, Tim10, Tim12 and Tim13.54 Other
examples include COX proteins – containing dual CX9Cmotifs –
that are involved in the maintenance of the respiratory chain
located in the mitochondrial inner membrane.55,56 Moreover, it
seems that the import of other vital proteins (e.g.Mrp10 & Atp23
into the intermembrane space and Tim22 into the inner
membrane) is dependent on their interactions with Mia40,
albeit without the requirement of their cysteine motifs.11 Tim22
is a translocase that does not have any CXnC motifs but still
relies on Mia40 for its correct import and insertion within the
inner membrane.10 These interactions display the importance
of this single oxidoreductase protein on the regulation and
maintenance of mitochondrial intermembrane space proteins.
It was discovered that a sequence which is not an N-terminal
sequence – and is common to many Mia40 substrates – exists
within these substrates and is vital for the substrate's specic
targeting capabilities to the mitochondrial intermembrane
space. This intermembrane space targeting signal (ITS), con-
sisting of 9 amino acids, is necessary for targeting of
intermembrane-space-targeted preproteins to Mia40; the ITS
functions by priming a cysteine residue within the substrate for
effective docking with Mia40's active-site-resident CPC motif.57
Deletion of this ITS has shown to completely abolish the import
of Mia40 substrates to the intermembrane space. The ITS
functions by forming a helix with its vital hydrophobic and
aromatic residues on the same side as this primed cysteine
residue. Here, this region of the helix interacts with and induces
the interaction of the substrate with the Mia40 oxidoreductase,
ultimately leading to further interaction through disulphide
bond formation.57,58
When Mia40 donates its disulphide to its substrates it stays
reduced. To function again it needs to be recycled back to its
oxidised state. This re-oxidation is ensured by a second© 2021 The Author(s). Published by the Royal Society of Chemistrycomponent of the MIA pathway: a avin adenine dinucleotide
(FAD)-linked sulydryl oxidase known as Erv1 (Essential for
respiration and viability 1).59 Erv1 is a Mia40 substrate with
a structure unlike any other Mia40 substrate, containing three
specic cysteine pairs that are highly conserved between species
(residues C30/C33, C130/C133 and C159/C176);11,56,59,60 Erv1 is
unable to oxidise proteins independently, although it can form
a higher ternary complex with Mia40 to achieve this effect.61
Specically, the rst pair of cysteines are involved in the specic
interaction of Erv1 with Mia40.62,63 The third pair of cysteines'
disulphide bond has a more structural role; interestingly, this
same disulphide is recognised by the Mia40 oxidoreductase
during the import of Erv1 into the intermembrane space,64 with
nal folding and maturation of Erv1 occurring with FAD
binding.59 Erv1 is a crucial component of the MIA oxidative
folding pathway and functions by removing electrons from
Mia40 and relaying them to either molecular oxygen or cyto-
chrome c,65,66 thereby producing either hydrogen peroxide
(H2O2) or water (H2O) respectively; water is produced from
cytochrome c's funnelling of electrons to oxygen linking thus
this oxidative folding pathway to the ETC. Specically, Erv1
functions by collecting electrons (through Mia40's N-terminal
CX2C motif) in its own CX2C motif. Here, the electrons are
transferred onto FAD, where they can then be relayed to either
molecular oxygen or cytochrome c. Although oxygen is generally
the nal electron acceptor, if electrons are relayed to cyto-
chrome c, alternative structures are known to be nal electron
acceptors – such as the cytochrome c heme lyase Ccp1.67 In
essence, through this specic electron relay, Erv1 recycles
Mia40 from a substrate-induced reduced state to a functional
oxidised state allowing Mia40 to continue its role as a ‘disul-
phide donor’. We should note that in human mitochondria, the
Mia40 homologue (Mia40 or CHCHD4) translocation to the
intermembrane space is dependent on the presence of the
human homologue of Erv1 (ALR) and an internal targeting
signal; this is due to the lack of an N-terminal membrane
anchor that is present in the S. cerevisiae homologue of Mia40.68
This further shows the importance of Erv1 to Mia40's general
function within the IMS.3. Types and structural features of
protein targeting signals for import into
mitochondria
Mitochondrial targeting signals can be considered as ‘post
codes’ that are necessary and sufficient when added to proteins
for their submitochondrial localisation.70 About two thirds of all
mitochondrial proteins are synthesized in the cytosol with
a cleavable presequence. Presequences are of variable length,
usually 18–50 amino acid residues, although very short (<10 aa)
and very long (up to 100 aa) ones have been observed.71,72 An
important characteristic of mitochondrial presequences is the
formation of an amphipathic a-helix that contains a positively
charged face and a hydrophobic face.73 The elements of the
amphipathic helix are specically recognised by receptors and
other import components during preprotein translocation byRSC Adv., 2021, 11, 32476–32493 | 32481
Table 1 Yeast mitochondrial proteins with N-terminal cleavable presequences. The positively-charged amino acid residues are shown in bold,
negatively-charged residues are shown in italic and hydrophobic residues are shown in regular font. The cleavage sites processed by the
mitochondrial processing peptidase (MPP) are mostly found in position R-2 and highlighted in cyan. Sequences were acquired from the
Saccharomyces Genome Database (SGD)/UniProt and analysed using the MitoFates prediction tool for mitochondrial targeting sequences
Protein Function N-terminal presequence
MPP cleavage
site
ACO1 Required for the tricarboxylic acid (TCA) cycle .IKRPIV– –RGLA.
HSP77 ATPase of the Hsp70 family, involved in protein translocation and folding .AAKNILNRSS. .RLQS.
TRX3 Thioredoxin required to maintain redox homeostasis in the cell .FYKPVMRMAVRPLKSI– –RFQS.
TUF1 Mitochondrial translation elongation factor MSALLPRLLTR. .RTFS.
XDJ1 Chaperone facilitating mitochondrial protein import; associated to Ydj1p .DRGDRLYDVL. .RKLA.
MXR2 Methionine-R-sulfoxide reductase, involved in the response to oxidative stress .LGKRICQEAVT. .RSGK.



























































































View Article Onlinethe import machinery.74 Although the components of the
import machinery have been well characterised as mentioned in
the rst part of this review, the cytosolic targeting steps and the
proteins involved in these are less well-understood. Specically,
it is still not clear for many mitochondrial proteins whether
their targeting signal can be recognised by one or many dedi-
cated targeting factors, the specicity of such targeting factors
and their interplay with the outer membrane receptor subunits
that decode the targeting signals.
The main entry gate of precursor proteins to mitochondria is
the translocase of the outer membrane (TOM) complex. The
TOM complex consists of multiple subunits; Tom20 has been
identied as the general receptor for protein sequences while
Tom70 may also have a role in signal recognition.75 Tom20 has
the monumental task of recognising roughly up to 1000 mito-
chondrial proteins, from non-mitochondrial ones, andFig. 3 Tom20 interactionwith the N-terminal presequence of aldehyde d
leucine while X can be any amino acid. (B) Helical wheel projection of the
hydrophobic side of the helix. (C) Interaction of the ALDH presequence
domains of Tom20. The hydrophobic surface of Tom20 is indicated in ye
ALDH (orange) at the Tom20 interface. ALDH residues are represented in
(PDB ID: 2V1S).
32482 | RSC Adv., 2021, 11, 32476–32493recognising at least four different classes of precursor proteins
with distinct targeting signals following various import path-
ways in the organelle.76,77 The import machinery not only
functions as recognitions stations for the mitochondrial tar-
geting signals but also as channels and driving forces for the
translocation of the preproteins (Table 1).743.1 Matrix targeting signals
The majority of the matrix proteins contain N-terminal cleav-
able mitochondrial sequences (MTS, Fig. 3). The MTS is 10–70
amino acids long, it is positively charged with a tendency to
form an amphipathic a-helix (Fig. 3B).71 A comparative analysis
of the N-proteome of mitochondria from mouse, human and
yeast revealed that although the N-terminus sequence is poorly
conserved, properties such as the length, charge and cleavageehydrogenase (ALDH). (A) Matrix targeting sequencemotif: L stands for
presequence peptide amphipathic helix. The blue arrow points to the
(orange) with the hydrophobic shallow groove of the helix-turn-helix
llow while the hydrophilic surface is light blue. (D) Contact residues of
orange. Yellow dashes indicated contact between two atoms (<4.0 Å)



























































































View Article Onlinesite are well conserved.78 These presequences are usually
removed in the matrix, aer import, by the matrix processing
peptidase (MPP). MPP cleavage typically occurs at two amino
acids C-terminal to an arginine (R-2).24,71
Tom20 recognises the hydrophobic side of the a-helix while
Tom22 is presumed to recognise the basic residues of the pre-
sequences and thus complement the receptor function of
Tom20.19,79 Previous analyses into the MTS consensus motif
(Fig. 3A) revealed the following motif: LSRLL where L represents
leucine (hydrophobic residue) and R is arginine (positively
charged residue). Although this a typical motif, Tom20 has been
shown to recognise a variety of this motif in other presequences
such as the LRRAY of the mitochondrial heat shock protein 60
(Hsp60). Nevertheless, the three lysine residues appear to be the
most important for preprotein recognition.76 Tom20 consists of
two helix-turn-helix domains, that create a shallow groove that
acts as the binding site for the presequence; the hydrophobic
residues are indicated in yellow while the hydrophilic ones are
presented in cyan (Fig. 3C). As seen in Fig. 3D, the three leucine
residues (orange) of the presequence interact with residues in
the groove (cyan). Leu150 and Leu190 are held in a hydrophobic
created by Ile74, Leu106 and Leu110 side chains of Tom20.
Leu180 on the other hand, makes contact with the Val109 and
Thr113 residues of the translocase.76
Aer recognition the presequence transverses the TOM
complex by consecutively binding a number of binding
presequence-binding sites spanning the channel formed by the
b-barrel protein.80,81 These binding sites are arranged by in
order of increasing affinity for the presequence, with the high-
affinity binding site found at the IMS side of the channel.82–85
Next, the presequence has to interact with the translocation
machinery of the inner membrane. The TIM23 channel consists
of Tim23, Tim50 and Tim17; Tim23 and Tim17 are structurally
similar and form the channel via which presequences are
translocated.86–88 Tim50 was later discovered to have an
important role in the transfer of proteins from the TOM to the
TIM23 channel.89–91 Additionally, Tim50 regulates the confor-
mation of the Tim23 channel by closing the channel in the
absence of the presequence in order to prevent ion leakage.
When the presequence binds Tom50, it subsequently leads to
a conformational change in Tim23 that causes the channel to
open.77 However, the two membranes are separated by the
intermembrane space which is an aqueous sub-compartment.
As a result, protein translocation needs to happen at the
contact sites where the outer membrane and inner membrane
are in close proximity. Once the presequence is translocated via
the TOM complex, its N-terminus reaches the TIM23 complex of
the inner membrane where a translocation intermediate is
formed.92–94 The presequence is now threaded through both the
TOM and TIM23 complex. This intermediate happens due to
the lack of membrane potential in the outer membrane
rendering the TOM complex a passive pore, incapable of
completing the translocation of the mitochondrial preprotein.
As a result, TIM23 provides a critical driving force for the
translocation of the N-terminal presequences. TIM23 requires
membrane potential and the activity of the matrix ATP-
dependent translocation motor14,74,95 chaperone heat shock© 2021 The Author(s). Published by the Royal Society of Chemistryprotein 70 (Hsp70) to drive the precursor protein across the
inner membrane and into the matrix.80,89,94,96
However, the protein is not functional yet and reaches its
mature form aer the presequence gets cleaved by the MPP.
MPP is a soluble matrix protein that processes the bulk of N-
terminal presequences.71,97 It is a heterodimer consisting of
two subunits: Mas1 which is the active site and Mas2 which
contains a glycine-rich loop which plays an important role in
presequence recognition.98,99 Although there is not a conserved
cleavage site motif, most cleavage sites have an arginine residue
situated two amino acids before the C-terminus (R-2, RXX) of
the presequence.71 Another element that helps MPP recognise
presequences for cleavage is an aromatic residue, such as
phenylalanine or tyrosine, at position +1.97,100 MPP is not the
only peptidase that can cleave N-terminal presequences as
recently the human insulin-degrading enzyme (IDE) and its
yeast homologue Ste23 have been linked to MTS cleavage and
clearance.101 Although IDE is mainly found in the cytosol, an
isoform resulting from the alternative translation of IDE local-
ises to mitochondria and is believed to have an MPP-like
function.102 Ste23 interacts with Cym1, an established peptide-
degrading enzyme in the matrix to degrade presequence
peptides and promote protein maturation.101 Presequence
cleavage is not only important for protein maturation but also
for cell viability. If MPP is impaired the preproteins will not
mature and thus the accumulation of unfolded proteins might
lead to aggregation in mitochondria.101,1033.2 Inner membrane targeting signals
Most inner membrane proteins belong to a family of solute
transport proteins (also calledmetabolite carrier proteins), such
as the ADP/ATP carrier, and contain six a-helical trans-
membrane domains. Unlike the aforementioned cleavable
presequences, carrier precursors contain internal targeting
elements that remain part of the mature protein.12,42 The carrier
protein precursors are guided primarily to the Tom70 receptor
of the TOM complex by cytosolic chaperones. Nonetheless,
there is growing evidence that Tom70 is not a selective receptor
protein strictly involved in mitochondrial protein import and it
functions as a versatile protein adaptor that facilitates the
interaction of mitochondria with different proteins but also
other organelles such as the ER.104 The carrier precursors are
inserted into the Tom40 channel in a loop formation with both
termini remaining exposed on the cytosolic side.42,77 Subse-
quently, chaperones are recruited in the IMS-side of Tom40 that
facilitate the translocation of the hydrophobic precursors and
protect them from aggregating or misfolding in the aqueous
phase. These chaperones are the small Tims, Tim9–10 and
Tim8–13, that we will discuss in detail in the next section. The
transient binding of the importing carrier proteins to the small
Tim chaperones is guided mainly by the transmembrane
segments of the carrier proteins that function as the internal
targeting signals.36,40 The presence of the entire sequence of the
carrier proteins is presumably necessary to ensure the correct
targeting of these proteins, since truncated versions of carrier



























































































View Article Onlineof cryptic matrix targeting signals that would be rendered non-
functional in the context of the entire protein and therefore
allow proper targeting to the inner membrane.105 The small Tim
chaperone complexes associate with the TIM22 complex of the
inner membrane to aid the transfer of the precursor protein for
nal insertion into the membrane. The TIM22 complex consists
of Tim18, Tim22 and Tim54, with Tim18 and Tim54 stabilising
the complex. TIM22 also requires the membrane potential in
order to facilitate the insertion of the transmembrane segments
of the integral inner membrane proteins.38,106–1083.3 Intermembrane space targeting signals
Although the IMS is the smallest mitochondrial subcompart-
ment, it is vital for mitochondrial function. It constitutes
a crucial buffer between the cytosol and matrix through the
exchange of lipids, proteins, metals and other cofactors neces-
sary for mitochondrial function, redox regulation and
apoptosis.10,71 Additionally, there are numerous protein import
pathways into the IMS perhaps indicative of its pleiotropic
nature. One well-characterised type of targeting signal for the
IMS is the bipartite presequence for a small number of IMS
proteins. Additionally, for the majority of IMS proteins contain
characteristic cysteine motifs48,109 and have their own unique
targeting signal. The proteins with bipartite presequences
contain an N-terminal mitochondrial targeting signal (MTS) as
well as a hydrophobic sorting region. The N-terminal part of the
presequence is similar to the cleavable mitochondrial targeting
presequences, hence it is positively charged and forms an
amphipathic helical structure. The positive domain of the
bipartite sequence is recognised by the TOM complex receptors
Tom20 and Tom22. This signal then allows the presequence to
transverse the Tom40 channel. Once in the IMS side of the TOM
complex (trans site), it is recognised by Tom50 that in turn feeds
the presequence to TIM23.74 The latter region, known as the
stop-transfer sequence, arrests translocation to the matrix
inserted as the hydrophobic segment gets “stuck” in the Tim23
channel. The transmembrane domain is then laterally diffused
and the presequence is anchored to the inner membrane with
the N-terminal peptide facing the matrix. The MPP then cleaves
the presequence to facilitate protein maturation.101 There is
a secondary cleavage site between the hydrophobic segment
and the mature protein facing the IMS. This motif is recognised
and cleaved by inner membrane peptidase (IMP).27,110 The IMP
is a heterodimer consisting of two different catalytic subunits;
the Imp1 and Imp2 that are anchored to the inner membrane by
their N-terminal domain. A third protein Som1 was shown to be
involved in the IMP complex and was found to be essential for
the proteolytic activity of the Imp1 subunit. The IMP complex
cleaves the transmembrane segment leading to the release of
the mature protein in the IMS.49
The majority of intermembrane space proteins lack these
bipartite presequences. Instead, they contain an internal, non-
cleavable targeting signal with hydrophobic residues and
characteristic cysteine motifs (CX3C and CX9C) that form
intramolecular disulphide bonds as a consequence of their
interaction with the MIA machinery. These targeting signals are32484 | RSC Adv., 2021, 11, 32476–32493termed mitochondrial IMS sorting signal (MISS) or the IMS
targeting signal (ITS). The ITS peptide is usually nine amino
acids-long and contains conserved residues that are important
for both substrate recognition and folding of the substrate
protein. The cysteine residues are usually separated by 3 or 9
amino acids, although some MIA substrates contain cysteines
not organised in a specic motif. A comprehensive protein
engineering and mutagenesis analysis has dened the
consensus motif in the ITS signal, CXX[Hy][Hy]XX[Ar]X, where
the hydrophobic residues in position 3 and 4 and an
aromatic residue in position 7 are strictly conserved
(Fig. 4A).57 The substrates of the Mia pathway are usually small
proteins that remain reduced in the cytosol and are translocated
to the IMS via the TOM channel. Once in the IMS, the ITS tar-
geting signal is recognised by the oxidoreductase Mia40. The
ITS forms an amphipathic a-helix with the hydrophobic face
containing the conserved residues that are necessary for
recognition and binding by Mia40 (Fig. 4B). Unlike the MTS
peptide for targeting to the matrix, the charged residues of the
ITS peptide are not functionally important.57 Recognition of the
ITS by Mia40 occurs via site-specic hydrophobic interactions
which allow a two-step disulphide bond formation event
between the CPC site of Mia40 and the substrate's internal
targeting signal (Fig. 4C and D).11,53,57,111 Folding of the substrate
occurs via two consecutive induced folding events, each one
coupled to one disulphide formation:
The rst ITS helix folding is induced by the substrate cle of
Mia40, coupled to the formation of the intermolecular disul-
phide. The second helix is induced by the now folded ITS rst
helix, coupled to the intramolecular disulphide formation
between the inner cysteines.
Covalent binding is thermodynamically essential to induce
the a-helical folding of the Mia40 substrates and stabilise the
protein–protein interactions. Once the disulphide bond
between Mia40 and the substrate is formed, entropic contri-
butions do not prevent the folding anymore and the formation
of the a-helix is thermodynamically favoured. Aer substrate
release, the Mia40 CPC motif remains reduced and gets reoxi-
dised by Erv1 back to its functional state as an IMS
receptor.62,112,113 The Mia40 has an expanded specicity by rec-
ognising substrates with unconventional cysteine motifs. For
example, Mix23 displays a CX14C/CX13C and Erv1 is imported
via a CXXC motif.3.4 Atypical IMS targeting signals
In addition to the majority of IM proteins that contain an ITS
targeting signal, there are proteins that have atypical targeting
signal which guide them into the IMS.
The case of cytochrome proteins. Cytochrome b2 and cyto-
chrome c1 follow the stop-transfer pathway, but their nal
localisation in the IMS depends additionally on a heme-binding
domain (HBD) downstream of the stop-transfer signal. When
their presequence is translocated across the outer membrane
into the IMS, the HBD domain can fold independently of the
presequence. As a result, the mature form of the HBD prevents
the backward movement of the presequence and thus the© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 4 Mia40 interactionwith theMISS/ITS peptide of Cox17. (A) Intermembrane space targeting sequencemotif: L stands for leucine while X can
be any amino acid. (B) Helical wheel projection of the presequence peptide amphipathic helix. The blue arrow points to the hydrophobic side of
the helix. (C) Interaction of the Cox17 ITS/MISS (green) with the hydrophobic cleft of Mia40. The hydrophobic surface of Mia40 is indicated in
yellow while the hydrophilic surface is light blue. (D) Contact residues of Cox17 (green) at the Tom20 interface. Cox residues are represented in



























































































View Article Onlinepresequence can only move forward into the IMS.27,74,114 The
HBD domain also drives the import of cytochrome C into the
IMS.115,116 Cytochrome C is one of the Cys containing proteins in
the IMS that exceptionally does not depend on the MIA pathway
for its import.48
Gpx3. Gpx3 is the major oxidative stress sensor in the
cytosol. A ribosomal proling study in S. cerevisiae provided
evidence that under H2O2 stress conditions, ribosomal
binding sites shied upstream of the endogenous AUG codon
leading to alternative translation.117 Gpx3 localises to the
cytosol when translated through its canonical AUG start
codon. However, under acute oxidative stress, an isoform of
the protein is synthesized, with and 18-amino acid N-terminal
peptide, from the translation of a non-AUG codon and is
translocated to mitochondria. The N18 peptide is mostly
hydrophobic and has positive charges but does not follow any
of the conventional protein import pathways into the inter-
membrane space.118 Intriguingly, the Gpx3 without the N-
terminal extension also gets targeted to mitochondria, albeit
in lower yields than the N-extended form, suggesting that an as
yet uncharacterised targeting signal must be present even in
the mature part of the protein.8 Gpx3 is not the only protein
that is dually localised in the IMS in addition to its cytosolic
localisation. Other such proteins are the thioredoxin 1 (Trx1)
and thioredoxin 2 (Trx2) and thioredoxin reductase Trr1,
which are both targeted to the IMS by yet unknown targeting
signals.119© 2021 The Author(s). Published by the Royal Society of Chemistry3.5 Outer membrane targeting signals
The outer membrane possesses two types of integral membrane
proteins: b-barrel and a-helical proteins. b-Barrel proteins are
integrated to the outer membrane by multiple b-strands
traversing the membrane while a-helical proteins are anchored
to the membrane by one or more transmembrane a-helices.2 b-
Barrel proteins make up two of the critical translocases of the
protein import pathway (the Tom40 and Sam50 channel form-
ing subunits of the TOM and SAM complex) and their function
is therefore essential. They are synthesised in the cytosol like
99% of mitochondrial proteins but do not contain a cleavable
targeting signal. Instead, the targeting signal of b-barrel
proteins is internal to the protein and remains part of the
mature protein. At rst, the b-strands on the proteins were
believed to be the targeting signal for these proteins but no
specic motif was identied.120 However, it was later discovered
that the actual targeting signal consists the most C-terminal b-
strand called the b-signal;121 the properties of the b-signal have
been further dissected to include high hydrophobicity and form
a beta hairpin element that can extend to include two adjacent
b strands that specically bind the translocation machinery.122
The b-hairpin is recognised by Tom20 and subsequently
translocated through the Tom40 channel. Upon translocation,
TIM chaperones in the IMS bind to precursor in order to prevent
aggregation in the aqueous sub-compartment. It is then trans-
ferred to the SAM complex, which is the central machinery for
the b-protein biogenesis pathway. The SAM complex contains



























































































View Article Onlinemembrane, as well as Sam35 and Sam37 that are peripheral
membrane proteins exposed to the cytosol. Sam35 and Sam50
cooperate in the recognition of the b-hairpin motif and direct
membrane insertion. The b-signal is then proposed to induce
the opening of the lateral gate of Sam50 which leads to the
lateral release of the protein to the outer membrane.2,121 Sam37
is understood to support the release of the b-barrel protein from
the SAM complex to the OM but the exact mechanism of the
release is not understood in great detail.123
The other group of OM proteins are a-helical OM proteins
that are anchored to the membrane by one or more a-helices.
There are no known examples of OM proteins that will have
both b-barrel structure and a-helical transmembrane domains.
They have various functions from protein transport to
apoptosis. The biogenesis of these proteins is only understood
in part. It appears that the positive charge and moderate
hydrophobicity of their membrane anchor acts as a targeting
signal.124 They are split into three main protein classes: signal-
anchored, tail-anchored and polytopic outer-membrane
proteins. Signal-anchored and tail-anchored proteins containTable 2 Targeting and sorting signals for the import of mitochondrial p
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32486 | RSC Adv., 2021, 11, 32476–32493an a-helical transmembrane section at the N- and C-terminus,
respectively. The transmembrane domain and its anking
regions function as both a membrane anchor and a targeting
signal. The exact targeting signal for polytopic proteins is not
known but it may be associated with the multiple trans-
membrane domains of the proteins. Tom70 is believed to be the
receptor for such proteins but it is unclear if they pass through
the Tom40 channel for their import.125 The MIM complex is
proposed to have a major role in this pathway; it can mediate
the transfer of substrates from the TOM complex as well as
promote the import and assembly of all types of a-helical
proteins (Table 2).2,1234. Chaperone-assisted protein
folding in the IMS
The specic translocon machineries and their interaction with
the variety of targeting signals that we have discussed so far
ensure the correct targeting and sorting of the importedroteins
Import machinery Example
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View Article Onlineproteins to the different mitochondrial sub-compartments.
However, as the transported proteins are targeted to the
organelle in a largely unfolded state (which allows them to
thread efficiently through the narrow translocon channels), they
need to be folded at the trans site inside the organelle aer the
transport process has been completed. The newly synthesised
proteins that are to be transported to mitochondria are kept
unfolded by a system of cytosolic chaperones to avoid protein
aggregation and premature damage.126 In mitochondria, dedi-
cated molecular chaperones assist the folding of newly impor-
ted proteins and prevent their aggregation while their
hydrophobic segments are transported through the aqueous
sub-compartments.
In the mitochondrial matrix, various molecular chaperones
have been identied that help newly imported proteins to fold.
These belong to the well characterised families of Hsp70 Hsp60
and their cochaperones Hsp40 an Hsp10. One key chaperone in
the matrix is for example the mitochondrial heat shock protein
(mtHsp70) is an ATP-dependent import motor of the TIM23
complex that not only helps drive protein translocation, but also
mediates the folding of the imported substrates.24,127
By contrast, the IMS presents several unique challenges as
a folding environment for the newly import proteins. First, the
IMS does not retain its own pool of ATP as the matrix, and in
fact there are no ATP-dependent chaperones in the IMS.128
Second, the IMS is the most constricted mitochondrial sub-
compartment, with local concentrations of proteins very high
and an increasing potential for aggregation, particularly for
proteins with exposed hydrophobic patches which are common
for the unfolded imported proteins. Finally, the extended
physical interactions between the outer and inner membranes
in contact sites and the internal segregation of the cristae
lumen separately from the boundary intermembrane space put
further constraints on the folding process in this compartment.
In this context, we will discuss in this chapter the three main
chaperone systems in the IMS. Namely, we will focus on the
structure and chaperone function of Mia40 as a holdase, theFig. 5 Structural features of human Mia40. (A) Structure of the protein co
well as Cys53 and Cys55 of the catalytically active CPC motif. (B) Hydro
and the adjacent CPC motif (PDB ID: 2K3J).
© 2021 The Author(s). Published by the Royal Society of Chemistryfunction of the small Tims as dedicated membrane protein
chaperones and nally the chaperone role of the protease Yme1.4.1 The Mia40 holdase
As previously described, several IMS proteins are required to go
through oxidative folding duringmaturation by interaction with
an oxidoreductase, namely Mia40 in yeast or its human
homolog CHCHD4.53,56 The most notable difference between
the two homologs is that the yeast variant contains a large N-
terminal extension of 242 amino acids that tethers the protein
into the inner membrane facing the IMS, while this segment is
absent in CHCHD4 resulting in the protein being entirely
soluble in the IMS. Despite their variance, they share a high
sequence identity in the central and catalytically active region of
the protein (residues 47–107 in CHCHD4 and residues 290–350
in yeast) which include the conserved cysteine residues in a –
CPC–CX9C–CX9C– motif. The Nuclear Magnetic Resonance
(NMR) structure of this segment for the human protein (Fig. 5)
revealed the protein core to be composed of 3 helices; a1
(residues 56–59) which is a very short helix that contains the
redox-active CPC motif and the only dened secondary struc-
ture of the N-terminal segment of the protein core; a2 (residues
65–77) and a3 (residues 88–100) form an antiparallel a-hairpin
that is stabilized by the disulphide pairs Cys64–Cys97 and
Cys74–Cys87. The NMR data obtained also suggests that the N-
terminal segment varies in exibility upon disulphide bond
formation in the CPC motif, thus otherwise referred to as the
“lid”.53 Mia40 substrates share a coil–helix coiled coil–helix
(CHCH) motif that is imported into mitochondria in a reduced
and unfolded form.34,52 The oxidative folding ability of Mia40
depends on the formation of transient intramolecular disul-
phide bridges between the Cys55 of the CPC motif and specic
cysteines of the substrate proteins. Successful binding achieves
a rapid disulphide exchange that results in the CHCH domain
of substrates being oxidised while Mia40 is reduced. Such
exchanges include the Cys45 in the CX9C motif of Cox17,53 and
the rst cysteine of the CX3C motif in Tim9 and Tim10 thatre (residues 49–109), highlighting intramolecular disulphide bridges as
phobicity surface, highlighting the hydrophobic substrate binding cleft



























































































View Article Onlineregulates the assembly of the TIM9$10 complex.37,129 Aside from
the oxidative function of Mia40, the orientation of the substrate
with the correct Cys to the CPC motif was found to be crucial to
achieving efficient disulphide exchange and strictly dependent
on hydrophobic packing between the ITS and the Mia40
substrate cle.57 TheMia40 structure revealed several conserved
hydrophobic residues on the a-helix opposite the CPC motif
made up of residues Leu42, Ile43, Ile49, Trp51, Leu56, Met59,
Ala60, Phe68, Phe72, Phe75, Phe91, Met94 and Met98. These
residues were collectively shown to be essential for cell
survival.53 The hydrophobic collapse of the ITS hydrophobic
residues, that make up the solvent-exposed hydrophobic
binding cle of Mia40, stabilise the unfolded substrate in the
IMS milieu, with Mia40 functioning as a holdase.57,130 This
initial step of substrate binding to Mia40 (and hence its chap-
erone activity) is independent of subsequent oxidation (i.e.
disulphide bonding) steps.57,112 In fact, the hydrophobic inter-
actions dictated by the substrate binding cle of Mia40 are also
involved in the recycling of Mia40 by Erv1. In this reaction, Erv1
binds to Mia40 in a manner that mimics the substrate
(‘substrate mimicry model’) and making use of an extended
hydrophobic patch in the intrinsically disordered N-terminal of
Erv1.62,63 While Mia40 catalyses disulphide bridges that ther-
modynamically favour a-helical folding for its substrates,131 in
vitro experiments of Koch et al., with Mia40 and Cox17 proposedFig. 6 Structure of the Tim9$10 and Tim8$13 complex. (A) Side view and
(D) top view of the Tim8$13 complex (PDB ID: 3CJH).
32488 | RSC Adv., 2021, 11, 32476–32493an additional proofreading ability for the chaperone by re-
shuffling incorrect disulphides within its substrate protein.1324.2 The small Tim chaperones for polytopic proteins
Among the substrates of Mia40 are the small Tims, a family of
10 kDa chaperones that exist within the IMS of mitochondria.
Their most well studied function is the transport metabolite
carriers across the IMS, by protecting exposed hydrophobic
regions of these integral membrane proteins.35,36,108 Addition-
ally, the small Tims also assist the integration of b-barrel
protein in the OM of mitochondria, making them the only
known chaperone system capable of interacting with both types
of membrane proteins (b-barrels and a-helical) the family
members include Tim8, Tim9, Tim10, Tim12 and Tim13 in S.
cerevisiae and are organised in specic oligomeric assemblies.
Tim9 pairs with Tim10 and Tim8 with Tim13. They share
a conserved CX3CXnCX3C motif (where n  15) or two CX3C
motifs that are essential for their function.52,129 Tim9 and Tim10
are essential proteins35,133 that share 22% sequence identity and
50% sequence similarity. By contrast, Tim8 and Tim13 are not
essential for viability. Following their import into the IMS, they
assemble into a thermodynamically stable 70 kDa hexameric
complex.37,134 Once assembled, Tim12, an essential subunit of
the TIM22 complex binds the Tim9$10 complex to enable (i)
substrate insertion into the inner membrane and (ii) dual(B) top view of the Tim9$10 complex (PBD ID: 2BSK). (C) Side view and
© 2021 The Author(s). Published by the Royal Society of Chemistry
Fig. 7 Cryo-EM structure of Yme1. This is the top view of the protein
showing the C6-symmetric protease ring that faces the intermem-
brane space. A central pore of 1.4 nm diameter is formed where the



























































































View Article Onlinelocalisation for the chaperone, in the bulk of the IMS and
tethered to the inner membrane in a Tim9$10$12 complex
intermediate.35,135 Folding of the unassembled Tim9 and Tim10
requires their oxidation by Mia40 and it is only the oxidised and
fully folded Tim9 and Tim10 that can assemble to form a func-
tional heterohexameric Tim9$10 chaperone complex.52,129,134
The secondary structure of the complex is exclusively a-helical,
where the two subunits alternate in a 6-fold molecular
symmetry to form a closed circular core. Each subunit folds into
a helix-loop-helix as disulphide bridges in-between CX3C motifs
create a central loop. The whole complex comprises 6 inner and
6 outer helices (Fig. 6). In the central part of the subunit, they
form a doughnut-shaped substrate-binding core around
a hollow pore of 15 Å, while the antiparallel N- and C-termini
extend downward of the core.134 Depending on the length of
the transferred protein, multiple chaperones may attach to the
same chain for its efficient protection.136 Sequence analysis of
small Tims identied a set of conserved hydrophobic residues
that face the binding cle found in-between the inner and outer
helices in both Tim9$10 and Tim8$13 complexes.137 Mutagen-
esis of these conserved residues to hydrophilic residues in
Tim9$10 resulted in cell death and are thus proposed to be
essential for the biogenesis of its substrate proteins.136However,
it could be argued that replacing multiple residues in the
protein core with amino acids of inverse physicochemical
properties likely affects the structure of the complex and elicit
this cell response. The ADP/ATP carrier protein AAC has been
widely reported to bind the Tim9$10 complex during its trans-
port through the IMS to the translocase Tim22.36,105,134 While the
transmembrane domains of AAC bind the Tim9$10 complex
core,36 Tim10 was shown to interact with AAC using its N-
terminal domain. The individual subunits' role in substrate
binding suggests that Tim9 has more of a structural role within
the complex while Tim10 maintains substrate specicity and
affinity.105 Though not essential in yeast, the Tim8$13 complex
was shown to be most important in low membrane potential
conditions.39 Import of its primary substrate, Tim23 is heavily
dependent on membrane potential. By binding the N-terminal
domain of Tim23, the Tim8$13 complex prevents protein
aggregation during import as well as prevents its retrograde
translocation.39,41 The Tim8$13 complex shares structural
similarities with Tim9$10 but have been shown to have different
substrate-binding preferences, as well as additional hydrophilic
interactions not reported in the Tim9$10 complex. It appears
the two complexes have separate roles within the IMS. However,
membrane precursor proteins were shown to be transferrable
from one TIM chaperone to the other, indicating a possibility
for cooperation in their chaperone activity.137Fig. 8 Side view of the cryo-EM structure of Yme1. The protein is
tethered to the inner mitochondrial membrane (IMM) by a membrane
helix. The subunits of the ATPase domain create an asymmetric
staircase while the protease ring subunits create a planar symmetric
C6 ring. The purple and green structures represent the different
translocases found on the IMM (PDB ID: 6AZ0).4.3 The Yme1: a protease with a chaperone activity
Yme1 is a member of conserved family of AAA+ ATPases that are
associated with a plethora of cellular processes.138 These
include: cellular quality control, organelle biogenesis,
membrane ssion and vesicular transport.139 Failure to sustain
protein quality control may lead to impaired cellular function
and as a result the development of numerous human© 2021 The Author(s). Published by the Royal Society of Chemistrydiseases.140 Yme1 is involved in mitochondrial protein quality
control and has been specically associated with the degrada-
tion or unfolded or damaged proteins. However, further
research has revealed an additional role of Yme1 as a molecular
chaperone assisting the folding of newly imported
polypeptides.141,142
Despite the crucial function of Yme1, little was known about
is structure until Puchades et al., took on the arduous task of
resolving its cryo-EM structure.138 Yme1 is a hexameric protein
and every subunit contains an ATPase and peptidase domain
(Fig. 7). As seen in Fig. 8, Yme1 is tethered to the inner
membrane by a membrane helix and its catalytic domains are
facing the IMS.143 Yme1 assembles into two stacked rings, with
the ATPase domains creating an asymmetric spiral staircase
above the protease ring. The staircase creates a central pore
(1.4 nm diameter) with a conserved aromatic-hydrophobic
motif that is essential for binding substrate proteins. ATPases
are ATP-driven machineries that are characterised by
a conserved P-looped AAA domain containing Walker A and
Walker Bmotifs. The AAA domain of Yme1 contains a conserved
Walker A motif, with the pattern G-X(4)-GK-[TS].144 Numerous



























































































View Article Onlinebinding substrates for translocation or degradation. It is also
hypothesised that this motif is involved when Yme1 binds
substrates to prevent aggregation or mediate protein folding.141
The AAA domain of Yme1 was rst shown to act as a chap-
erone by binding to unfolded protein dihydrofolate reductase
(DHFR) in in vitro experiments using isolated mitochon-
dria.141,145 Moreover, it was suggested that Yme1 assists with the
folding/assembly of Cox2, a subunit part of the catalytic core of
cytochrome c oxidase. Thus, supporting that Yme1 acts as
a chaperone also in vivo conditions.146 Later research conrmed
the role of Yme1 as a folding helper for DHFR in the IMS.
Importantly, the chaperone activity of Yme1 was independent
from its protein degradation function. The study also identied
numerous endogenous substrates that aggregate in the absence
of Yme1. These proteins are necessary for the aforementioned
functions of the IMS, thus further supporting the importance of
Yme1.142 Interestingly, Erv1 was identied as one of the
endogenous substrates of Yme1. As mentioned above, Erv1 is an
essential component of the oxidative folding pathway. There-
fore, Yme1 presumably has a crucial role in a variety of mito-
chondrial pathways.
Despite the growing evidence in support of Yme1 as a chap-
erone in the IMS, the mechanism of its function is not yet clear.
It is hypothesized that Yme1 binds newly imported proteins
during their translocation and assists with their folding.
Another hypothesis is that the AAA domain of Yme1 binds
unfolded proteins and helps keep them in a folding-competent
state to enable their refolding. If folding is unsuccessful, then
the proteins get degraded by the proteolytic domain of Yme1.142
The cryo-EM structure of Yme1 has given a better picture of the
architecture of the protein and the residues involved in
substrate binding.138 Nevertheless, the exact mechanism of the
chaperone activity of Yme1 still needs to be determined.
The different chaperone systems in the IMS (Mia40, small
Tims and Yme1) seem to display specicity against their
substrates with no overlap in their function. However, the small
Tims interact both with Mia40 as a substrate and they also seem
to be subject to quality control by the Yme1. It is not yet very
clear whether other proteins may be processed by more than
one of the IMS chaperone systems.
5. Conclusions
Mitochondria have developed multiple import pathways to
accommodate the import of the different types of proteins
needed for mitochondrial function. Most mitochondrial sub-
compartments have typically one or two major import path-
ways, but the intermembrane space seems to divert with a very
high variety of pathways, some of which are dictated by target-
ing signals that are still either completely unknown or poorly
understood. This is surprising given that the IMS is the smallest
mitochondrial sub-compartment, but it is perhaps indicative of
the pleiotropic function of the IMS.
The emergence of new IMS proteins carrying atypical signals
is of great interest as not much is known about targeting signal
specicity and its recognition by the various import compo-
nents. Furthermore, there is growing evidence that proteins like32490 | RSC Adv., 2021, 11, 32476–32493the Mia40, the small Tims and Yme1 have more functions than
previously anticipated. Taken together, thesemight suggest that
mitochondria have found ways to evolve in order to recognise
novel targeting signals or have developed such alternative
import pathways as a backup when mitochondrial function is
impaired. Thus, it is important to dissect how these uncon-
ventional targeting pathways work in order to better understand
mitochondrial function and how it can be altered to prevent
disease progression.
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71 F. N. Vögtle, S. Wortelkamp, R. P. Zahedi, D. Becker,
C. Leidhold, K. Gevaert, J. Kellermann, W. Voos,
A. Sickmann, N. Pfanner and C. Meisinger, Cell, 2009,
139, 428–439.
72 S. Backes and J. M. Herrmann, Front. Mol. Biosci., 2017, 4,
83.
73 D. Roise, F. Theiler, S. J. Horvath, J. M. Tomich,
J. H. Richards, D. S. Allison and G. Schatz, EMBO J., 1988,
7, 649–653.
74 T. Endo, H. Yamamoto and M. Esaki, J. Cell Sci., 2003, 116,
3259–3267.
75 T. Endo and D. Kohda, Biochim. Biophys. Acta, Mol. Cell Res.,
2002, 1592, 3–14.
76 T. Saitoh, M. Igura, T. Obita, T. Ose, R. Kojima, K. Maenaka,
T. Endo and D. Kohda, EMBO J., 2007, 26, 4777–4787.
77 N. Bolender, A. Sickmann, R. Wagner, C. Meisinger and
N. Pfanner, EMBO Rep., 2008, 9, 42–49.
78 S. E. Calvo, O. Julien, K. R. Clauser, H. Shen, K. J. Kamer,
J. A. Wells and V. K. Mootha, Mol. Cell. Proteomics, 2017,
16, 512–523.32492 | RSC Adv., 2021, 11, 32476–3249379 J. Brix, K. Dietmeier and N. Pfanner, J. Biol. Chem., 1997,
272, 20730–20735.
80 T. Bausewein, D. J. Mills, J. D. Langer, B. Nitschke,
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